High-volume centres achieve excellent long-term survival and low reoperation rates in mitral valve repair—key findings ...
With new transcatheter options for the repair or replacement of tricuspid valves, the role and timing of repair — whether surgical or minimally invasive — is entering a time of transition.
The tricuspid valve is anatomically complex. It’s often called the “forgotten valve” because of its position in the back of ...
As tools become more precise and non-invasive, doctors are able to diagnose and treat heart conditions with greater accuracy ...
Minimally invasive heart procedures like transcatheter aortic valve replacement (TAVR) and MitraClip placement to treat ...
Edwards Lifesciences Corporation (NYSE:EW), a leading medical technology company specializing in heart valve therapies and critical care technologies with a market capitalization of $44.9 billion, has ...
THE Charlotte Maxeke Johannesburg Academic Hospital (CMJAH) has become the first health facility in Gauteng to successfully ...
The revolutionary BiVACOR heart device was moved to Phase 2 of FDA trials after success in five human patients.
Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter and full-year ended Dec. 31, 2024.
Vizient Quality and Accountability Ranking. Ranked #1 out of 115 participating comprehensive academic medical centers." ...
Investment analysts at Leerink Partnrs lowered their Q1 2025 earnings per share estimates for shares of Edwards Lifesciences ...
Stratos Wealth Partners LTD. lowered its holdings in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) by 2.0% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results